1. Pink Sheet
  2. >>Geography
  3. >>Asia
  4. >>India

CDER’s Counter-Terrorism, Emergency Coordination Operations Get New Home

 
• By Sue Sutter

Agency staff involved in medical countermeasure drug development and coordination of emergency activities will move into CDER director’s office, which also now houses the drug shortages program.

The Center for Drug Evaluation and Research’s decision to move counter-terrorism and emergency coordination functions into the center director’s office reflects the cross-cutting aspects of the program and the importance of its work to CDER’s mission, FDA said.

Establishment of the Counter-Terrorism and Emergency Coordination Staff under the Office of the Center Director was one of three organizational...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from India

More from Asia

To Compete With China, US FDA Must Deregulate Early Gene Therapy Studies, CAR-T Inventor Says

 
• By Sarah Karlin-Smith

FDA regulation was painted as an obstacle to US dominance in the cell and gene therapy space even as panelists at an agency event praised the Office of Therapeutic Products' track record under Nicole Verdun.

New Era Begins In Korea: Policy Predictions For Biopharma

 
• By Jung Won Shin

As South Korea's new president immediately gets to work on setting initial policies, essential drug supplies, R&D incentives and AI-driven digital healthcare are among the key topics in focus.

Australia Looks To Modernize Human Tissue Laws, Improving Access For Researchers

 
• By Eliza Slawther

Australia is reviewing its human tissue laws for the first time in almost 50 years, and is hoping to reduce barriers to access for scientific researchers, for instance by addressing issues with access to cell lines for developing drugs.